Glenmark Pharma receives ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg
Glenmark Pharmaceuticals Ltd. is an integrated, research‐led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.